487 related articles for article (PubMed ID: 18442718)
1. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
4. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
[TBL] [Abstract][Full Text] [Related]
5. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
6. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
7. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
8. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
11. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
[TBL] [Abstract][Full Text] [Related]
12. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
14. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
15. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome.
Crispim JC; Mendes-Junior CT; Wastowski IJ; Costa R; Castelli EC; Saber LT; Donadi EA
Tissue Antigens; 2008 Jan; 71(1):35-41. PubMed ID: 17971051
[TBL] [Abstract][Full Text] [Related]
16. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
Dijke IE; Velthuis JH; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
Transplantation; 2007 Jun; 83(11):1477-84. PubMed ID: 17565321
[TBL] [Abstract][Full Text] [Related]
17. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring.
Torres MI; Luque J; Lorite P; Isla-Tejera B; Palomeque T; Aumente MD; Arizon J; Peña J
Hum Immunol; 2009 Oct; 70(10):830-5. PubMed ID: 19638290
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
19. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.
Gonzalez-Stawinski GV; Cook DJ; Chui J; Gupta S; Navia JL; Hoercher K; Taylor DO; Yamani MH; Starling RC; Smedira NG
J Surg Res; 2007 Oct; 142(2):233-8. PubMed ID: 17727888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
